CNSP Share Price Performance
US$6.49
-70.19 (-91.54%)
Price US$6.49
Share Pricen/a
CNS Pharmaceuticals, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
CNSP Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
CNS Pharmaceuticals, Inc. Key Details
About CNSP
- Founded
- 2017
- Employees
- 5
- CEO
- WebsiteView website
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company’s drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
